Annual Long Term Debt
$45.68 M
+$39.72 M+666.22%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual long term debt is $45.68 million, with the most recent change of +$39.72 million (+666.22%) on December 31, 2023.
- During the last 3 years, INZY annual long term debt has risen by +$44.40 million (+3449.49%).
- INZY annual long term debt is now at all-time high.
Performance
INZY Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$42.23 M
-$3.52 M-7.70%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly long term debt is $42.23 million, with the most recent change of -$3.52 million (-7.70%) on September 30, 2024.
- Over the past year, INZY quarterly long term debt has dropped by -$3.52 million (-7.70%).
- INZY quarterly long term debt is now -7.70% below its all-time high of $45.75 million, reached on June 30, 2024.
Performance
INZY Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
INZY Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +666.2% | -7.7% |
3 y3 years | +3449.5% | +608.3% |
5 y5 years | - | +608.3% |
INZY Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +1630.4% | -7.7% | +1785.2% |
5 y | 5-year | at high | +3449.5% | -7.7% | +3181.2% |
alltime | all time | at high | +3449.5% | -7.7% | +3181.2% |
Inozyme Pharma Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $42.23 M(-7.7%) |
Jun 2024 | - | $45.75 M(+0.1%) |
Mar 2024 | - | $45.70 M(+0.0%) |
Dec 2023 | $45.68 M(+666.2%) | $45.68 M(+37.5%) |
Sep 2023 | - | $33.21 M(-0.1%) |
Jun 2023 | - | $33.26 M(+28.8%) |
Mar 2023 | - | $25.82 M(+333.1%) |
Dec 2022 | $5.96 M | $5.96 M(-2.4%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $6.11 M(+172.7%) |
Jun 2022 | - | $2.24 M(-8.3%) |
Mar 2022 | - | $2.44 M(-7.5%) |
Dec 2021 | $2.64 M(+105.1%) | $2.64 M(-6.7%) |
Sep 2021 | - | $2.83 M(-6.1%) |
Jun 2021 | - | $3.01 M(-5.7%) |
Mar 2021 | - | $3.19 M(+148.2%) |
Dec 2020 | $1.29 M | $1.29 M |
FAQ
- What is Inozyme Pharma annual long term debt?
- What is the all time high annual long term debt for Inozyme Pharma?
- What is Inozyme Pharma annual long term debt year-on-year change?
- What is Inozyme Pharma quarterly long term debt?
- What is the all time high quarterly long term debt for Inozyme Pharma?
- What is Inozyme Pharma quarterly long term debt year-on-year change?
What is Inozyme Pharma annual long term debt?
The current annual long term debt of INZY is $45.68 M
What is the all time high annual long term debt for Inozyme Pharma?
Inozyme Pharma all-time high annual long term debt is $45.68 M
What is Inozyme Pharma annual long term debt year-on-year change?
Over the past year, INZY annual long term debt has changed by +$39.72 M (+666.22%)
What is Inozyme Pharma quarterly long term debt?
The current quarterly long term debt of INZY is $42.23 M
What is the all time high quarterly long term debt for Inozyme Pharma?
Inozyme Pharma all-time high quarterly long term debt is $45.75 M
What is Inozyme Pharma quarterly long term debt year-on-year change?
Over the past year, INZY quarterly long term debt has changed by -$3.52 M (-7.70%)